NASDAQ · EARS
Altamira Therapeutics Ltd.
Healthcare · Biotechnology
$3.05
Down-$0.05 (-1.77%)
Updated Aug 23, 2026, 8:06 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.21M
- P/E ratio
- -0.02
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 174.07K
- Avg. volume
- 1.89M
Price performance
EARS price history
1M range · 0 trading sessions · Daily adjusted prices
EARS does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest EARS news
The latest Smart Investors Daily articles mentioning EARS.
Stock researchCompany · Overview
EARS research
Overview
Company profile and research snapshot.
Company profile
Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurotology and central nervous system disorders. The company is headquartered in Zug, Zug and currently employs 11 full-time employees. The firm focuses on the development of intranasal betahistine for the treatment of vertigo (AM-125) and for the treatment of antipsychotic-induced weight gain and somnolence (AM-201). The betahistine program is in Phase 1 of clinical trials. Other programs in the Company's product pipeline include brimapitide-based AM-111 for the treatment of acute inner ear hearing loss and eskatemine-based Keyzilen (AM-101) for the treatment of acute inner ear tinnitus, both in Phase 3 of clinical trials, as well as AM-102 indicated for tinnitus, undergoing preclinical studies focused on selecting the lead compound. The firm operates through subsidiaries in Switzerland, Ireland and the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Apr 13, 2017 | Roth Capital | Buy | — |
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
